Affiliation: Novartis Institutes for BioMedical Research
- Intraarticular drug delivery in osteoarthritisNicole Gerwin
Bone and Cartilage Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, WKL 125 13 59, CH 4002 Basel, Switzerland
Adv Drug Deliv Rev 58:226-42. 2006..The development of novel drugs in combination with new formulations for IA treatment of OA, represents a promising approach in this challenging area of research...
- The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the ratN Gerwin
Novartis Institutes for BioMedical Research, Musculoskeletal Disease Area, 4002 Basel, Switzerland
Osteoarthritis Cartilage 18:S24-34. 2010..The aim of this study was to describe a histologic scoring system for use in different models of OA in rats that allows standardization and comparison of results obtained by different investigators...
- ADAMTS-1, a gene product of articular chondrocytes in vivo and in vitro, is downregulated by interleukin 1betaLydia Wachsmuth
Cartilage Research Unit, Department of Pathology, University of Erlangen Nurnberg, Erlangen, Germany
J Rheumatol 31:315-20. 2004....